Skip to main content

Select Drug Profiles

Biomarkers, Oncology
Larotrectinib Has Wide-Ranging Efficacy in Advanced Solid Tumors with NTRK Gene Fusion
Wayne Kuznar
Wayne Kuznar
Read More
Cholangiocarcinoma, Oncology
Expanding Treatment Options for Patients with Advanced Cholangiocarcinoma
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
Enfortumab Vedotin Promising Third-Line Option for Metastatic Urothelial Cancer
Phoebe Starr
Phoebe Starr
Read More
FDA Approvals
Selective, Small-Molecule DRD2 Antagonist Induces Tumor Regression in Recurrent High-Grade Glioma
Wayne Kuznar
Read More
FDA Approvals
Autologous Mesothelin-Targeted T-Cells Induce Responses in Pleural Solid Tumors
Wayne Kuznar
Wayne Kuznar
Read More
Immunotherapy, Oncology
Applying CAR T-Cell Therapies to Solid Tumors: Overcoming Current Challenges
Chase Doyle
Chase Doyle
Read More
Disparities in Oncology, Oncology
ASCO 2019 Presidential Address: Removing Disparities in Cancer Care
Wayne Kuznar
Wayne Kuznar
Read More
Practice Management
Patient Navigators, Clinician Education Can Remove Barriers to Enrollment in Clinical Trials
Chase Doyle
Chase Doyle
Read More
Pediatric Cancer, Oncology
The Pediatric MATCH Study: Actionable Targets Found in 25% of Young Patients with Cancer
Wayne Kuznar
Wayne Kuznar
Read More
Practice Management
FDA Unveils Oncology-Specific “Project Facilitate,” Expanding Access to Investigational Cancer Drugs
Phoebe Starr
Phoebe Starr
Read More
Page 47 of 244
Results 461 - 470 of 2438